Cargando…
Efficacy of Clopidogrel and Clinical Outcome When Clopidogrel Is Coadministered With Atorvastatin and Lansoprazole: A Prospective, Randomized, Controlled Trial
This prospective, randomized, nonblind, controlled trial evaluated the effects of clopidogrel on platelet function upon coadministration with atorvastatin and lansoprazole. One hundred four adult patients with non-ST-segment elevated acute coronary syndrome (NSTE-ACS) who underwent percutaneous coro...
Autores principales: | Zhang, Jian-rong, Wang, Di-qing, Du, Jun, Qu, Guang-su, Du, Jian-lin, Deng, Song-bai, Liu, Ya-jie, Cai, Jin-xi, She, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058921/ https://www.ncbi.nlm.nih.gov/pubmed/26683949 http://dx.doi.org/10.1097/MD.0000000000002262 |
Ejemplares similares
-
Investigation of the interaction between proton pump inhibitors and clopidogrel using VerifyNow P2Y12 assay
por: Lin, Sheng-Feng, et al.
Publicado: (2020) -
Influence of proton pump inhibitors on clinical outcomes in coronary heart disease patients receiving aspirin and clopidogrel: A meta-analysis
por: Hu, Wen, et al.
Publicado: (2018) -
CYP2C19 loss-of-function alleles are not associated with clinical outcome of clopidogrel therapy in patients treated with newer-generation drug-eluting stents
por: Choi, Ik Jun, et al.
Publicado: (2016) -
Associations between P2RY12 gene polymorphisms and risks of clopidogrel resistance and adverse cardiovascular events after PCI in patients with acute coronary syndrome
por: Li, Miaonan, et al.
Publicado: (2017) -
Comparison between ticagrelor versus clopidogrel in long term outcomes of Taiwanese diabetic subjects with acute coronary syndrome undergoing successful revascularization: From TSOC ACS-DM registry
por: Wang, Cheng-An, et al.
Publicado: (2020)